Neogen® Launches DNA Test for Beef-on-Dairy Cattle

News provided by

Jun 06, 2023, 08:45 ET

LINCOLN, Neb., June 6, 2023 /PRNewswire/ -- Neogen^® Corporation (NASDAQ: NEOG) announced today that it has launched Igenity^® BeefXDairy, a new and novel leading genomic test for beef-on-dairy calves.

Genetic testing is critical to the efficient management and marketing of beef-on-dairy cattle, and the new Igenity BeefXDairy test provides producers with insight into key traits such as carcass quality, average daily gain, and the Igenity Terminal Index, which can then be used to market the calf's growth potential to buyers. The test will also allow buyers to receive breed composition data (e.g., percentage beef vs. percentage dairy) to help them best manage those cattle for optimal health and maximum growth.

"Neogen is excited to be the first to offer up a commercial genomic tool for this growth cattle market," said Shelby Smith, Bovine Genomics Product Manager at Neogen. "This product offering is a massive step forward in helping to characterize beef-on-dairy animals and allowing dairy producers, cattle buyers, and, ultimately, consumers of beef products to benefit. With increased DNA testing, we can enable improved quality, efficiency, and sustainability within beef production systems."

Neogen Genomics constantly provides high quality data to assist with herd improvement and improve cattle operations, and the new Igenity BeefXDairy test is another tool allowing producers to glean valuable data they need to advance and grow their operations efficiently and sustainably.

To learn more about the new Igenity BeefXDairy test or our other genomics solutions for cattle, contact Neogen by calling 877.443.6589, send an email to [email protected], visit neogen.com, or contact your local Territory Manager.

About Neogen

Neogen Corporation develops and markets comprehensive solutions dedicated to food and animal safety, operating with the intention to "Every day, protect the people and animals we care about." The Company's Food Safety segment markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases, and sanitation concerns. Neogen's Animal Safety segment is a leader in the development of genomic solutions along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care, and disinfectants, as well as rodent and insect control solutions.

Contact: Shelby Smith, Bovine Genomics Product Manager
402.435.0665, x7248, [email protected]

SOURCE Neogen Corporation